ARTA
WST icon

A.R.T. Advisors’s West Pharmaceutical WST Stock Holding History

A.R.T. Advisors’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-900
Closed -$204K – 265
2020
Q2 		$204K Buy
+900
New +$177K 0.31% 150
2020
Q1 		– Sell
-9,700
Closed -$1.46M – 1004
2019
Q4 		$1.46M Sell
9,700
-15,900
-62% -$2.32M 0.07% 420
2019
Q3 		$3.63M Buy
25,600
+1,300
+5% +$179K 0.18% 116
2019
Q2 		$3.04M Buy
24,300
+12,500
+106% +$1.48M 0.17% 141
2019
Q1 		$1.3M Buy
11,800
+9,000
+321% +$936K 0.08% 383
2018
Q4 		$274K Buy
2,800
+800
+40% +$86.8K 0.02% 957
2018
Q3 		$246K Buy
+2,000
New +$224K 0.01% 1124
2017
Q3 		– Sell
-21,400
Closed -$2.02M – 1711
2017
Q2 		$2.02M Buy
+21,400
New +$1.97M 0.11% 274
2016
Q4 		– Sell
-3,200
Closed -$238K – 1421
2016
Q3 		$238K Sell
3,200
-1,264
-28% -$100K 0.08% 424
2016
Q2 		$338K Sell
4,464
-24,300
-84% -$1.77M 0.02% 933
2016
Q1 		$1.99M Sell
28,764
-500
-2% -$30.1K 0.09% 333
2015
Q4 		$1.76M Buy
+29,264
New +$1.76M 0.08% 336
2013
Q4 		– Sell
-6,330
Closed -$260K – 1546
2013
Q3 		$260K Buy
+6,330
New +$241K 0.01% 1029

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

A.R.T. Advisors's WST Position: Q3 2020 in Review

A.R.T. Advisors sold out of West Pharmaceutical (WST) in Q3 2020, closing a stake of 900 shares — an estimated $204K sold.

A.R.T. Advisors first reported a position in WST in Q3 2013 and held it in 13 quarters. The position peaked at $3.63M in Q3 2019. 574 funds tracked by Wall St. Rank hold WST as of Q3 2020.

  • A.R.T. Advisors reported no remaining West Pharmaceutical position as of Q3 2020 after selling out during the quarter.
  • A.R.T. Advisors sold 900 West Pharmaceutical shares in Q3 2020, an estimated $204K.
  • A.R.T. Advisors first reported a position in West Pharmaceutical in Q3 2013 and held it in 13 quarters.
  • A.R.T. Advisors's West Pharmaceutical position peaked at $3.63M in Q3 2019.
  • 574 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2020.

Based on A.R.T. Advisors's 13F filing for Q3 2020, filed 16 Nov 2020.